Traveka Wealth’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Traveka Wealth's AMGN Position: Q2 2026 in Review
Traveka Wealth increased its Amgen (AMGN) stake by 5.9% in Q2 2026, buying an estimated $17.8K and bringing the position to 926 shares worth $335K. The position accounts for 0.11% of the portfolio, ranked #125.
Traveka Wealth first reported a position in AMGN in Q4 2023 and has held it in 8 quarters since. 1,625 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Traveka Wealth held 926 shares of Amgen worth $335K as of Q2 2026.
- Traveka Wealth bought 52 Amgen shares in Q2 2026, an estimated $17.8K.
- Amgen made up 0.11% of Traveka Wealth's portfolio in Q2 2026, its #125 holding.
- Traveka Wealth first reported a position in Amgen in Q4 2023 and has held it in 8 quarters since.
- 1,625 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Traveka Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.